Free Trial

Compare Stocks

Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities.

CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
Decibel Therapeutics, Inc. stock logo
DBTX
Decibel Therapeutics
$4.91
-0.8%
$5.00
$1.61
$5.40
$123.39M-0.43122,002 shs1.26 million shs
EMC Corp stock logo
EMC
EMC
$29.28
-0.1%
$0.00
$22.99
$29.13
N/AN/A13.90 million shs4,651 shs
IMV Inc. stock logo
IMV
IMV
$0.66
$0.48
$12.70
$9.63M0.95233,607 shs44,800 shs
Neptune Wellness Solutions Inc stock logo
NEPT
Neptune Wellness Solutions
$0.39
$0.19
$28.00
$906K2.19462,687 shs2.25 million shs
The Best High-Yield Dividend Stocks for 2025 Cover

Discover the 10 Best High-Yield Dividend Stocks for 2025 and secure reliable income in uncertain markets. Download the report now to identify top dividend payers and avoid common yield traps.

Get This Free Report

Compare Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
Decibel Therapeutics, Inc. stock logo
DBTX
Decibel Therapeutics
0.00%0.00%0.00%0.00%0.00%
EMC Corp stock logo
EMC
EMC
-0.06%+0.64%+5.40%+13.19%+6.67%
IMV Inc. stock logo
IMV
IMV
0.00%0.00%0.00%0.00%0.00%
Neptune Wellness Solutions Inc stock logo
NEPT
Neptune Wellness Solutions
0.00%0.00%0.00%0.00%0.00%
CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & Valuation
Decibel Therapeutics, Inc. stock logo
DBTX
Decibel Therapeutics
N/AN/AN/AN/AN/AN/AN/AN/A
EMC Corp stock logo
EMC
EMC
N/AN/AN/AN/AN/AN/AN/AN/A
IMV Inc. stock logo
IMV
IMV
N/AN/AN/AN/AN/AN/AN/AN/A
Neptune Wellness Solutions Inc stock logo
NEPT
Neptune Wellness Solutions
N/AN/AN/AN/AN/AN/AN/AN/A
CompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current Price
Decibel Therapeutics, Inc. stock logo
DBTX
Decibel Therapeutics
0.00
N/AN/AN/A
EMC Corp stock logo
EMC
EMC
0.00
N/AN/AN/A
IMV Inc. stock logo
IMV
IMV
0.00
N/AN/AN/A
Neptune Wellness Solutions Inc stock logo
NEPT
Neptune Wellness Solutions
0.00
N/AN/AN/A
CompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/Book
Decibel Therapeutics, Inc. stock logo
DBTX
Decibel Therapeutics
N/AN/AN/AN/A$3.28 per shareN/A
EMC Corp stock logo
EMC
EMC
N/AN/AN/AN/AN/AN/A
IMV Inc. stock logo
IMV
IMV
$330K0.00N/AN/A($0.69) per share0.00
Neptune Wellness Solutions Inc stock logo
NEPT
Neptune Wellness Solutions
$52.62M0.00N/AN/A($91.90) per share0.00
CompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings Date
Decibel Therapeutics, Inc. stock logo
DBTX
Decibel Therapeutics
-$63.01M-$2.53N/AN/AN/AN/A-84.03%-53.90%N/A
EMC Corp stock logo
EMC
EMC
N/A$2.0514.28N/AN/AN/AN/AN/A
IMV Inc. stock logo
IMV
IMV
-$37.99M-$4.59N/AN/AN/A-11,547.42%-12,695.41%-104.84%N/A
Neptune Wellness Solutions Inc stock logo
NEPT
Neptune Wellness Solutions
-$60.46M-$106.72N/AN/AN/A-128.13%N/A-141.94%N/A
CompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive Growth
Decibel Therapeutics, Inc. stock logo
DBTX
Decibel Therapeutics
N/AN/AN/AN/AN/A
EMC Corp stock logo
EMC
EMC
$0.461.57%N/A22.44%N/A
IMV Inc. stock logo
IMV
IMV
N/AN/AN/AN/AN/A
Neptune Wellness Solutions Inc stock logo
NEPT
Neptune Wellness Solutions
N/AN/AN/AN/AN/A
CompanyDebt-to-Equity RatioCurrent RatioQuick Ratio
Decibel Therapeutics, Inc. stock logo
DBTX
Decibel Therapeutics
N/A
3.03
3.03
EMC Corp stock logo
EMC
EMC
N/AN/AN/A
IMV Inc. stock logo
IMV
IMV
N/A
2.93
2.93
Neptune Wellness Solutions Inc stock logo
NEPT
Neptune Wellness Solutions
N/A
0.23
0.10

Institutional Ownership

CompanyInstitutional Ownership
Decibel Therapeutics, Inc. stock logo
DBTX
Decibel Therapeutics
69.59%
EMC Corp stock logo
EMC
EMC
79.86%
IMV Inc. stock logo
IMV
IMV
15.37%
Neptune Wellness Solutions Inc stock logo
NEPT
Neptune Wellness Solutions
14.44%

Insider Ownership

CompanyInsider Ownership
Decibel Therapeutics, Inc. stock logo
DBTX
Decibel Therapeutics
35.60%
EMC Corp stock logo
EMC
EMC
0.40%
IMV Inc. stock logo
IMV
IMV
0.33%
Neptune Wellness Solutions Inc stock logo
NEPT
Neptune Wellness Solutions
5.10%
CompanyEmployeesShares OutstandingFree FloatOptionable
Decibel Therapeutics, Inc. stock logo
DBTX
Decibel Therapeutics
6825.13 million16.18 millionNot Optionable
EMC Corp stock logo
EMC
EMC
N/AN/AN/ANot Optionable
IMV Inc. stock logo
IMV
IMV
9711.71 million11.67 millionOptionable
Neptune Wellness Solutions Inc stock logo
NEPT
Neptune Wellness Solutions
584.53 million4.30 millionNot Optionable

Recent News About These Companies

t20 world cup 2020 teams
Neptune Wellness Solutions Inc. (NEPTF)
The Aesthetic Experience introduces AE Wellness
Neptune Beach, FL Weather Conditions
Decibel Therapeutics stock logo

Decibel Therapeutics NASDAQ:DBTX

Decibel Therapeutics, Inc., a clinical-stage biotechnology company, engages in discovering and developing transformative treatments for hearing and balance disorders. The company's product candidates and programs focuses on three areas, such as Gene Therapies for Congenital, Monogenic Hearing Loss designed to restore functional cells within the cochlea to address hearing disorders caused by single gene mutations; Gene Therapies for Hair Cell Regeneration designed to replace lost hair cells within the inner ear to address acquired hearing loss and balance disorders; and Otoprotection Therapeutic in clinical development to prevent hearing loss in cancer patients undergoing chemotherapy with cisplatin. Its lead gene therapy product candidate is DB-OTO to provide hearing to individuals born with profound hearing loss due to mutation of the otoferlin gene. The company is also developing DB-ATO and AAV.201, a gene therapy program designed to restore balance in patients with bilateral vestibulopathy by regenerating lost hair cells within the vestibule; DB-020 for the prevention of cisplatin-induced hearing loss, which is in Phase 1b clinical trial; AAV.103 to restore hearing in individuals with a gap junction beta-2 (GJB2) deficiency; AAV.104 to restore hearing in individuals with stereocilin (STRC) deficiency; and cochlear hair cell regeneration program, an AAV-based gene therapy that utilizes cell-selective expression of reprogramming factors to convert supporting cells into outer hair cells. Decibel Therapeutics, Inc. has a strategic collaboration with Regeneron Pharmaceuticals, Inc. to develop gene therapies for monogenic forms of congenital hearing loss. The company was formerly known as Hearing Inc. and changed its name to Decibel Therapeutics, Inc. in April 2014. Decibel Therapeutics, Inc. was incorporated in 2013 and is headquartered in Boston, Massachusetts. As of September 25, 2023, Decibel Therapeutics, Inc. operates as a subsidiary of Regeneron Pharmaceuticals, Inc.

EMC stock logo

EMC NYSE:EMC

EMC Corporation (EMC) develops, delivers and supports the information technology (IT) industry's range of information infrastructure and virtual infrastructure technologies, solutions and services. EMC manages the Company as part of a federation of businesses: EMC Information Infrastructure, VMware Virtual Infrastructure, Pivotal and Virtustream. EMC's Information Infrastructure business provides a foundation for organizations to store, manage, protect, analyze and secure information. EMC's VMware Virtual Infrastructure business is engaged in virtualization and cloud infrastructure solutions that enable businesses to help transform the way they build, deliver and consume IT resources in a manner that is based on their specific needs. EMC's Pivotal business unites strategic technology, people and programs from EMC and VMware and has a platform that consists of data, agile development practices and a cloud independent platform-as-a-service.

IMV stock logo

IMV NASDAQ:IMV

IMV, Inc. is a clinical-stage biopharmaceutical company, which engage in providing a novel class of cancer immunotherapies and vaccines against infectious diseases including COVID-19. Its immune-educating technology includes DPX which is designed to inform a specific, coordinated, and persistent anti-tumor immune response. The company was founded on May 18, 2007 and is headquartered in Dartmouth, Canada.

Neptune Wellness Solutions stock logo

Neptune Wellness Solutions NASDAQ:NEPT

Neptune Wellness Solutions Inc., a health and wellness products company, specializes in the extraction, purification and formulation of cannabis products, as well as other specialty ingredients, such as MaxSimil, a patented ingredient that enhances the absorption of lipid-based nutraceuticals, and various other marine and seed oils. Its custom formulations are available in various delivery forms, such as softgels, liquid solutions, nutritional emulsions, and chewables. Neptune Wellness Solutions Inc. was founded in 1998 and is headquartered in Laval, Canada.